Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology
NSE:BAJAJHCARE

BAJAJ HEALTHCARE LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹314.00
at close · 8 Oct 2026
▼ 8.15 (-2.53%)

Latest filings

  1. Trading Window Closed Ahead of Q2 FY27 Results · Compliance
  2. AGM results: all 6 resolutions passed; Rs. 1.50 dividend declared · Compliance
  3. 33rd AGM of Bajaj Healthcare held; 6 resolutions passed including Rs 1.50 dividend · Board & Shareholder Meetings
All filings ↓
Ask Nexa about BAJAJ HEALTHCARE LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹628 Cr over the trailing twelve months.

Market Cap
₹1,057 Cr
P / E (TTM)
58.1×
EV / EBITDA
15.1×
Div Yield
0.30%
Growth
-1.4%▼
Revenue 5y CAGR
PAT -28.3% · EBITDA -11.3%
Quality
13.2%▲
ROCE (5y median)
ROE 8.5% (5y median) · margin 12.9%
Leverage
0.44·
Debt / Equity · low
Net debt ₹196 Cr
Revenue FY21→FY26
0.9×▼
Margin −10.1 pts
₹657 Cr → ₹611 Cr
Cash conversion
1.75×▲
Operating cash ÷ profit · 5 yrs
₹150 Cr on ₹86 Cr
Moves on a normal day
1.28%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#127/158
P/B#52/163
ROCE#127/183
ROE#129/166
Debt / Equity#129/166
EBITDA margin#81/165
Revenue growth#90/161
Profit growth#93/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Over 5 years it reported ₹86 Cr of profit and ₹150 Cr of operating cash — 1.75×
Profit is converting into cash
Pays out 20% of profit as dividend
Concerns
Revenue shrinking over 5 years (−1% a year)
Profit shrinking over 5 years (−28% a year)
Erratic profits — up in only 1 of the last 5 years
Carries more debt than its peers — 0.44× equity
higher than 78% of its 166 Pharmaceuticals peers
Heavy working capital — 200 days of cash tied up
Customers are taking longer to pay — 55 → 140 days of receivables
FY21 → FY26
EPS grew slower than profit — the share count rose (bonus or dilution)

Charts

How has the market priced it — with filings on the timeline?

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from BAJAJ HEALTHCARE LIMITED's filed financials and exchange disclosures

What does BAJAJ HEALTHCARE LIMITED do?

BAJAJ HEALTHCARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol BAJAJHCARE.

Is BAJAJ HEALTHCARE LIMITED profitable?

Yes. Over the trailing twelve months BAJAJ HEALTHCARE LIMITED reported a net profit of ₹18 Cr on revenue of ₹628 Cr.

Does BAJAJ HEALTHCARE LIMITED pay a dividend?

Yes. The dividend yield is 0.30% at the current price. It paid out 20% of its profit as dividend in FY26.

Is BAJAJ HEALTHCARE LIMITED debt-free?

No. It reported borrowings of ₹233 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹196 Cr after cash. Debt stands at 0.44× equity. That is higher than 78% of its 166 Pharmaceuticals peers.

Is BAJAJ HEALTHCARE LIMITED expensive compared with its peers?

On trailing P/E, BAJAJ HEALTHCARE LIMITED ranks 127 of 158 in Pharmaceuticals — cheaper than 20% of them, against an industry median of 32.1×. This is a position, not a valuation judgement.

How much does the BAJAJ HEALTHCARE LIMITED share price move in a day?

On a typical session BAJAJ HEALTHCARE LIMITED moves 1.28% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track BAJAJ HEALTHCARE LIMITED's announcements?

Every NSE and BSE filing by BAJAJ HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.